14-034

Dagseting: 

Þriðjudagur, 18. mars 2014

Fundur númer: 

378

Fjöldi mála á fundi: 

48

Heiti verkefnis: 

EudraCT no.:2013-000747-11. A randomized, double-blind, multicenter study to demonstrate equivalent efficacy and to compare safety and immunogenicity of a biosimilar adalimumab (GP2017) and Humira in patients with moderate to severe chronic plaque-type psoriasis.

Ábyrgðarmaður: 

Bárður Sigurgeirsson

Fundinn sátu: 

Kristján Erlendsson, formaður, Ingibjörg Harðardóttir, Kristín Benediktsdóttir, Henry A. Henrysson, Elín Margrét Hallgrímsdóttir, Helga Bragadóttir og Magnús Jóhannsson